1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [7e4cf99a-93bc-488e-8f59-c45ff867fc02] => Array ( [runtime-id] => 7e4cf99a-93bc-488e-8f59-c45ff867fc02 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [209c1b76-12b8-493e-8e64-7ed973a2b208] => Array ( [runtime-id] => 209c1b76-12b8-493e-8e64-7ed973a2b208 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;8c2a31119d97c3c07c946289455023101d6b063c ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => OpenAccess [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [eb1b2b66-5a34-4831-b3da-fc06d808e406] => Array ( [runtime-id] => eb1b2b66-5a34-4831-b3da-fc06d808e406 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => OpenAccess [privilege] => Array ( [99849949-abb5-42a1-b6fd-6205453b2349] => Array ( [runtime-id] => 99849949-abb5-42a1-b6fd-6205453b2349 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;8c2a31119d97c3c07c946289455023101d6b063c ) ) ) RT Journal Article SR Electronic T1 Correlation of MR Relative Cerebral Blood Volume Measurements with Cellular Density and Proliferation in High-Grade Gliomas: An Image-Guided Biopsy Study JF American Journal of Neuroradiology JO Am. J. Neuroradiol. FD American Society of Neuroradiology SP 501 OP 506 DO 10.3174/ajnr.A2312 VO 32 IS 3 A1 Price, S.J. A1 Green, H.A.L. A1 Dean, A.F. A1 Joseph, J. A1 Hutchinson, P.J. A1 Gillard, J.H. YR 2011 UL http://www.ajnr.org/content/32/3/501.abstract AB BACKGROUND AND PURPOSE: As newer MR imaging techniques are used to assist with tumor grading, biopsy planning, and therapeutic response assessment, there is a need to relate the imaging characteristics to underlying pathologic processes. The aim of this study was to see how rCBV, a known marker of tumor vascularity, relates to cellular packing attenuation and cellular proliferation. MATERIALS AND METHODS: Nine patients with histologically proved high-grade gliomas and 1 with a supratentorial PNET requiring an image-guided biopsy were recruited. Patients underwent a DSC study. The rCBV at the intended biopsy sites was determined by using a histogram measure to derive the mean, maximum, and 75th centile and 90th centile values. This measure was correlated with histologic markers of the MIB-1 labeling index (as a marker of glioma cell proliferation) and the total number of neoplastic cells in a high-power field (cellular packing attenuation). RESULTS: There was a good correlation between rCBV and MIB-1 by using all the measures of rCBV. The mean rCBV provided the best results (r = 0.66, P < .001). The only correlation with cellular packing attenuation was with the 90% centile (rCBV90%, r = 0.36, P = .03). The increase in rCBV could be seen over 1 cm from the edge of enhancement in 4/10 cases, and at 2 cm in 1/10. CONCLUSIONS: rCBV correlated with cellular proliferation in high-grade gliomas but not with cellular packing attenuation. The increase in rCBV extended beyond the contrast-enhancing region in 50% of our patients. CBVcerebral blood volumeDSCdynamic susceptibility-weighted contrast-enhanced perfusion MR imagingmaxmaximumMIB-1a monoclonal antibody directed against the Ki-67 antigenNSnot significantPETpositron-emission tomographyPNETprimitive neuroectodermal tumorrCBVrelative CBVrCBV75%75th percentile CBVrCBV90%90th percentile rCBVrCBVmaxmaximum rCBVrCBVmeanmean rCBVSPGRspoiled gradient-recalledVEGFvascular endothelial growth factorWHOWorld Health Organization